Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

NCT01492881 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Doxil is currently unavailable

Conditions

Multiple Myeloma

Interventions

DRUG: Vorinostat
DRUG: Bortezomib
DRUG: pegylated liposomal doxorubicin

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]